Simplex Trading’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $94.4K | Buy |
+3,811
| New | +$90.8K | ﹤0.01% | 5153 |
|
|
2025
Q3 | – | Sell |
-2,499
| Closed | -$51.4K | – | 9192 |
|
|
2025
Q2 | $54K | Sell |
2,499
-762
| -23% | -$18K | ﹤0.01% | 5847 |
|
|
2025
Q1 | $79K | Buy |
+3,261
| New | +$73.4K | ﹤0.01% | 5308 |
|
|
2024
Q4 | – | Sell |
-2,986
| Closed | -$64.1K | – | 8649 |
|
|
2024
Q3 | $59K | Buy |
2,986
+353
| +13% | +$6.54K | ﹤0.01% | 5741 |
|
|
2024
Q2 | $40K | Buy |
+2,633
| New | +$41K | ﹤0.01% | 6296 |
|
|
2024
Q1 | – | Sell |
-21,074
| Closed | -$318K | – | 8970 |
|
|
2023
Q4 | $354K | Buy |
21,074
+20,207
| +2,331% | +$276K | ﹤0.01% | 4054 |
|
|
2023
Q3 | $10K | Sell |
867
-8,703
| -91% | -$116K | ﹤0.01% | 7163 |
|
|
2023
Q2 | $128K | Buy |
+9,570
| New | +$138K | ﹤0.01% | 4786 |
|
|
2023
Q1 | – | Sell |
-11,001
| Closed | -$181K | – | 9152 |
|
|
2022
Q4 | $204K | Buy |
11,001
+2,925
| +36% | +$45K | ﹤0.01% | 4201 |
|
|
2022
Q3 | $103K | Buy |
8,076
+5,121
| +173% | +$60.7K | ﹤0.01% | 5484 |
|
|
2022
Q2 | $20K | Sell |
2,955
-17,963
| -86% | -$132K | ﹤0.01% | 7599 |
|
|
2022
Q1 | $173K | Buy |
20,918
+17,227
| +467% | +$122K | ﹤0.01% | 5356 |
|
|
2021
Q4 | $24K | Sell |
3,691
-73,709
| -95% | -$485K | ﹤0.01% | 8145 |
|
|
2021
Q3 | $448K | Sell |
77,400
-400
| -0.5% | -$2.19K | ﹤0.01% | 4259 |
|
|
2021
Q2 | $447K | Buy |
77,800
+70,043
| +903% | +$361K | ﹤0.01% | 4340 |
|
|
2021
Q1 | $35K | Sell |
7,757
-28,623
| -79% | -$114K | ﹤0.01% | 6989 |
|
|
2020
Q4 | $121K | Buy |
+36,380
| New | +$122K | ﹤0.01% | 5243 |
|
|
2020
Q3 | – | Sell |
-9,166
| Closed | -$35.8K | – | 7863 |
|
|
2020
Q2 | $42K | Sell |
9,166
-18,205
| -67% | -$81.8K | ﹤0.01% | 5638 |
|
|
2020
Q1 | $105K | Sell |
27,371
-44,659
| -62% | -$183K | ﹤0.01% | 4322 |
|
|
2019
Q4 | $270K | Sell |
72,030
-9,922
| -12% | -$46.4K | ﹤0.01% | 3418 |
|
|
2019
Q3 | $435K | Buy |
81,952
+68,798
| +523% | +$367K | ﹤0.01% | 2761 |
|
|
2019
Q2 | $50K | Sell |
13,154
-15,381
| -54% | -$66.4K | ﹤0.01% | 4860 |
|
|
2019
Q1 | $145K | Buy |
28,535
+25,542
| +853% | +$75.1K | ﹤0.01% | 3944 |
|
|
2018
Q4 | $5K | Sell |
2,993
-6,102
| -67% | -$17.5K | ﹤0.01% | 6193 |
|
|
2018
Q3 | $34K | Buy |
+9,095
| New | +$28.5K | ﹤0.01% | 5521 |
|
|
2018
Q1 | – | Sell |
-1,112
| Closed | -$4K | – | 6238 |
|
|
2017
Q4 | $4K | Sell |
1,112
-1,382
| -55% | -$4.57K | ﹤0.01% | 4658 |
|
|
2017
Q3 | $6K | Sell |
2,494
-915
| -27% | -$2.51K | ﹤0.01% | 4211 |
|
|
2017
Q2 | $9K | Buy |
+3,409
| New | +$7.12K | ﹤0.01% | 4046 |
|
|
2015
Q3 | – | Sell |
-4,299
| Closed | -$18.6K | – | 5586 |
|
|
2015
Q2 | $17K | Buy |
+4,299
| New | +$17.1K | ﹤0.01% | 2609 |
|
|
2015
Q1 | – | Sell |
-4,087
| Closed | -$12K | – | 5019 |
|
|
2014
Q4 | $12K | Buy |
+4,087
| New | +$11.2K | ﹤0.01% | 2440 |
|
Other funds holding CPRX
VCM
DM
VPM
Simplex Trading's CPRX Position: Q1 2026 in Review
Simplex Trading opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 3,811 shares worth $94.4K. The stake represents ﹤0.01% of the portfolio and ranks #5153 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CPRX as recently as Q2 2025.
Simplex Trading first reported a position in CPRX in Q4 2014 and has held it in 30 quarters since. The position peaked at $448K in Q3 2021. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Simplex Trading held 3,811 shares of Catalyst Pharmaceutical worth $94.4K as of Q1 2026.
- Catalyst Pharmaceutical was a new Simplex Trading position in Q1 2026.
- Catalyst Pharmaceutical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5153 holding.
- Simplex Trading first reported a position in Catalyst Pharmaceutical in Q4 2014 and has held it in 30 quarters since.
- Simplex Trading's Catalyst Pharmaceutical position peaked at $448K in Q3 2021.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.